Author:
Badkar Advait V.,Smith Alan M.,Eppstein Jonathan A.,Banga Ajay K.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Organic Chemistry,Pharmaceutical Science,Pharmacology,Molecular Medicine,Biotechnology
Reference33 articles.
1. S. Pestkaand and A. Meager. Interferon standardization and designations. J. Interferon. Cytokine Res. 17(Suppl 1):S9–S14 (1997).
2. P. Jouet, F. Roudot-Thoraval, D. Dhumeaux, and J. M. Metreau. Comparative efficacy of interferon alfa in cirrhotic and noncirrhotic patients with non-A, non-B, C hepatitis. Le groupe Francais pour l’etude du traitement des hepatites chroniques NANB/C. Gastroenterology 106:686–690 (1994).
3. S. Schenker, D. Cutler, J. Finch, C. H. Tamburro, M. Affrime, R. Sabo, and M. Bay. Activity and tolerance of a continuous subcutaneous infusion of interferon-alpha2b in patients with chronic hepatitis. C. J. Interferon. Cytokine Res. 17:665–670 (1997).
4. V. Bocci, F. Carraro, A. Naldini, P. P. Cagol, E. M. Pasqual, C. Prevaldi, and D. Casara. Distribution of human recombinant interferon-alpha 2 in rat plasma, liver, and experimental liver metastases. Mol. Biother. 2:233–234 (1990).
5. A. Bonettiand, and S. Kim. Pharmacokinetics of an extended-release human interferon alpha-2b formulation. Cancer Chemother. Pharmacol. 33:258–261 (1993).
Cited by
78 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献